Elanco Animal Health Incorporated
ELAN
$9.57
$0.1051.11%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 0.50% | 1.99% | 3.86% | -1.76% | 0.11% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.50% | 1.99% | 3.86% | -1.76% | 0.11% |
| Cost of Revenue | 3.73% | 8.32% | 8.93% | 2.85% | 0.94% |
| Gross Profit | -2.01% | -2.72% | 0.08% | -5.19% | -0.52% |
| SG&A Expenses | 2.19% | 0.93% | 1.33% | 2.06% | 1.59% |
| Depreciation & Amortization | -3.83% | -0.93% | 2.65% | 4.19% | 3.79% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.35% | 4.38% | 5.47% | 2.84% | 1.59% |
| Operating Income | -22.36% | -25.65% | -14.08% | -44.14% | -15.13% |
| Income Before Tax | 140.84% | 135.61% | -1,096.15% | -3,210.26% | -1,559.72% |
| Income Tax Expenses | 316.67% | 1,692.31% | 22.22% | 184.62% | 500.00% |
| Earnings from Continuing Operations | 127.46% | 117.92% | -1,010.62% | -4,907.69% | -1,478.21% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 127.46% | 117.92% | -1,010.62% | -4,907.69% | -1,478.21% |
| EBIT | -22.36% | -25.65% | -14.08% | -44.14% | -15.13% |
| EBITDA | -9.47% | -10.28% | -5.33% | -16.49% | -3.57% |
| EPS Basic | 127.38% | 117.83% | -1,003.51% | -4,757.72% | -1,465.04% |
| Normalized Basic EPS | -192.00% | -265.95% | -127.39% | -161.32% | -98.24% |
| EPS Diluted | 126.71% | 117.12% | -992.90% | -4,780.70% | -1,426.75% |
| Normalized Diluted EPS | -222.22% | -269.85% | -128.49% | -161.77% | -98.72% |
| Average Basic Shares Outstanding | 0.35% | 0.49% | 0.63% | 0.76% | 0.81% |
| Average Diluted Shares Outstanding | 0.58% | 0.72% | 0.68% | 0.82% | 0.68% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |